MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.06.25 Share Price

Warrant

DE000ME6VDA6

Market Closed - Börse Stuttgart 09:51:54 31/05/2024 pm IST
0.034 EUR -.--% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/140/0.1/20.06.25
Current month-15.00%
1 month-15.00%
Date Price Change
31/24/31 0.034 -.--%
30/24/30 0.034 -5.56%
29/24/29 0.036 +5.88%
28/24/28 0.034 +6.25%
27/24/27 0.032 -8.57%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 09:51 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN ME6VDA
ISINDE000ME6VDA6
Date issued 12/01/2024
Strike 140 $
Maturity 20/06/2025 (384 Days)
Parity 10 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.092
Lowest since issue 0.024
Spread 0.006
Spread %15.00%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.37 USD
Average target price
94.07 USD
Spread / Average Target
+15.61%
Consensus